Kiromic BioPharma Inc. (NASDAQ:KRBP) does about 109.39K shares in volume on a normal day but saw 3714288 shares change hands in Monday trading. The company now has a market cap of 4.95M USD. Its current market price is $0.28, marking an increase of 33.56% compared to the previous close of $0.21. The 52 week high reached by this stock is $1.26 whilst the lowest price level in 52 weeks is $0.15. The script in recent trading has seen the stock touch a high of $0.28 and a low of $0.2039.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Kiromic BioPharma Inc. (KRBP) has a 20-day trading average at $0.1952 and the current price is -78.02% off the 52-week high compared with 84.67% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2300 and its 200-day simple moving average is $0.3727. If we look at the stock’s price movements over the week, volatility stands at 16.15%, which increases to 18.75% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 67.97 to suggest the stock is neutral.
The current price level is 45.74%, 20.37%, and -26.25% away from its SMA20, SMA50, and SMA200 respectively, with the KRBP price moving below the 50-day SMA on January 23. Kiromic BioPharma Inc. (KRBP) stock is up 31.78% over the week and 45.79% over the past month. Its price is 53.29% year-to-date and -78.02% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2022, with the company’s earnings per share (EPS) of -$0.54 below consensus estimates by -$0.16. The company’s next earnings report is expected on 05/12/2023, with forecasts estimating quarterly EPS at -$0.56 and -$2.15 for whole year. KRBP’s earnings per share are forecast to grow by 4.90% this year and -10.20% over next year.
Outstanding shares total 15.84M with insiders holding 17.21% of the shares and institutional holders owning 6.81% of the company’s common stock. The company has a return on equity of -238.10%. Price to book ratio is 13.85.
USAA Extended Market Index Fund cut their holdings by -100.00% in the company over the course of the most recent quarter. It now holds a 0.00% position in Kiromic BioPharma Inc. thanks to 0.0 shares amounting to $0.0.
